First Demonstrated Replication of a Randomized Controlled Trial on Electronic Health Record Data Using the Clinical Intelligence Platform (CLINT)
Did you know around 80% of non-COVID-19 clinical trials have been suspended, stopped, or delayed? The long-term impact on clinical trials is amongst the many threats this virus has presented. HealthPals has identified an unrealized solution in external control arms (ECAs), which can both accelerate time-to-market and lower R&D and RCT costs.
To demonstrate the ability of CLINT to leverage ECAs, HealthPals, in collaboration with Veradigm, successfully replicated the Rocket-AF study in real-world EHR data. Read more for details on the replication results, and how ECAs can change the future of clinical trials